← Back to headlines

BioNTech Faces Economic Challenges After COVID Vaccine Success
BioNTech, the company behind a major COVID-19 vaccine, is reportedly facing an 'end of an era' as it navigates economic challenges, cuts, and closures after its pandemic-era billions. The company is now placing a significant bet on its cancer research.
14 May, 18:21 — 14 May, 18:21
Coverage Timeline
First report: protothema-en · 14 May, 18:21|Full coverage: 2 · 57m|Window: 57m
Left-leaningCenterRight-leaning



